%0
Generic
%T
Keynote-365 cohort a: Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC).
%A Yu, Evan Y.
%A Massard, Christophe
%A Retz, Margitta
%A Tafreshi, Ali
%A Carles Galceran, Joan
%A Hammerer, Peter
%A Fong, Peter C.C.
%A Shore, Neal D.
%A Joshua, Anthony
%A Linch, Mark David
%A Gurney, Howard
%A Romano, Emanuela
%A Augustin, Marinela
%A Piulats, Josep M.
%A Wu, Haiyan
%A Schloss, Charles
%A Poehlein, Christian Heinrich
%A De Bono, Johann S.
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%D 2019
%C American Society of Clinical Oncology (ASCO)